View Single Post
Old 01-06-2007, 08:49 AM
reverett123's Avatar
reverett123 reverett123 is offline
In Remembrance
 
Join Date: Aug 2006
Posts: 3,772
15 yr Member
reverett123 reverett123 is offline
In Remembrance
reverett123's Avatar
 
Join Date: Aug 2006
Posts: 3,772
15 yr Member
Default Diet and dyskinesias

Ron-

I have the Leaders' book and reccomend it. Each of us has a different metabolism and manifest PD differently as a result. The only way to manage it is to figure out our own picture by experiment and recording the results. (I know I'm preaching to the choir here and am really talking to those yet to be convinced )

I myself, despite every bit of medical advise, find I do best with lots of protein all morning long. Others are rendered catatonic by such a diet.

On the matter of dyskinesias, you might be interested in this recent report using fish oil:

1: Ann Neurol. 2006 Feb;59(2):282-8.

Docosahexaenoic acid reduces levodopa-induced dyskinesias in
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.

Samadi P, Gregoire L, Rouillard C, Bedard PJ, Di Paolo T, Levesque D.

Centre de recherche en Neurosciences, Centre Hospitalier Universitaire de Quebec
(CHUQ), Ste-Foy, Quebec, Canada.

OBJECTIVE: The objective of the present study was to investigate the effect of
docosahexaenoic acid (DHA), a polyunsaturated fatty acid (omega-3), on
levodopa-induced dyskinesias (LIDs) in parkinsonian
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys. METHODS: We
explored the effect of DHA in two paradigms. First, a group of MPTP monkeys was
primed with levodopa for several months before introducing DHA. A second group
of MPTP monkeys (de novo) was exposed to DHA before levodopa therapy. RESULTS:
DHA administration reduced LIDs in both paradigms without alteration of the
anti-parkinsonian effect of levodopa indicating that DHA can reduce the severity
or delay the development of LIDs in a nonhuman primate model of Parkinson's
disease. INTERPRETATION: These results suggest that DHA can reduce the severity
or delay the development of LIDs in a nonhuman primate model of Parkinson's
disease. DHA may represent a new approach to improve the quality of life of
Parkinson's disease patients.

PMID: 16437566 [PubMed - indexed for MEDLINE]
__________________
Born in 1953, 1st symptoms and misdiagnosed as essential tremor in 1992. Dx with PD in 2000.
Currently (2011) taking 200/50 Sinemet CR 8 times a day + 10/100 Sinemet 3 times a day. Functional 90% of waking day but fragile. Failure at exercise but still trying. Constantly experimenting. Beta blocker and ACE inhibitor at present. Currently (01/2013) taking ldopa/carbadopa 200/50 CR six times a day + 10/100 form 3 times daily. Functional 90% of day. Update 04/2013: L/C 200/50 8x; Beta Blocker; ACE Inhib; Ginger; Turmeric; Creatine; Magnesium; Potassium. Doing well.
reverett123 is offline   Reply With QuoteReply With Quote